BioNTech
This role involves developing antibody drug conjugates (ADCs) within a collaborative, cross-functional team, requiring close coordination with internal CMC teams and external partners like CROs and CDMOs. The position focuses on providing chemistry expertise for protein degraders, molecular glues, payloads, and linkers to support preclinical documentation and GMP manufacturing. Candidates are expected to drive creative research and consistent delivery while maintaining strong interpersonal and networking skills.
Headquarters
Mainz, Rhineland-Palatinate, Germany
Company Size
1001-5000 employees
Founded
2008
BioNTech is a biotechnology company that develops mRNA-based cancer immunotherapies, next-generation immunomodulators and targeted oncology therapies, and vaccines against infectious diseases. It combines proprietary mRNA, cell- and gene-based platforms to design both individualized and off-the-shelf treatments and advance programs through preclinical and clinical development. The company gained global prominence through its collaboration with Pfizer on an mRNA COVID-19 vaccine and pursues broad partnerships and scaled manufacturing to bring therapies to patients worldwide. BioNTech emphasizes translational science and personalized medicine to transform outcomes in oncology and infectious disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioNTech.
59% above the average for this role